NCT03549858 Patient Reported Outcomes Burdens and Experiences - Phase 3
| NCT ID | NCT03549858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McMaster University |
| Condition | Hemophilia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PROBE Phase-3 study will collect data on patient reported outcomes, burdens, and experiences in patients living with hemophilia. The investigators will perform comparisons among countries, within country over time, within country against national normative data.
Eligibility Criteria
Inclusion Criteria: * PWH will be recruited through national hemophilia patient organizations utilizing their existing membership rosters, social media outlets and meetings / events. The investigators are not proposing a pre-determined method of PWH recruitment. They will utilize the information acquired in the workshop and take-home project to inform best practice in recruitment methodology for the study. The investigators may consider requesting different countries test different PWH recruitment strategies to test reproducibility. In the future, the questionnaire might also be administered to patients with other chronic conditions. Exclusion Criteria: * Disease severity and Age bands or age limits (e.g. ≥ Age 18) may be utilized to narrow the study population.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03549858 clinical trial?
This trial is open to participants of all sexes, studying Hemophilia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03549858 currently recruiting?
Yes, NCT03549858 is actively recruiting participants. Contact the research team at mskinnerdc@gmail.com for enrollment information.
Where is the NCT03549858 trial being conducted?
This trial is being conducted at Hamilton, Canada.
Who is sponsoring the NCT03549858 clinical trial?
NCT03549858 is sponsored by McMaster University. The trial plans to enroll 1,000 participants.